Cyclo Therapeutics rises on European patent for Alzheimer's disease drug
** Shares of drug developer Cyclo Therapeutics Inc CYTH.O
rise 10.6% to $1.77 premarket
** Company says it has received European patent for its
experimental injection to treat early Alzheimer's disease
** The patent covers co's drug candidate, trappsol cyclo,
which is in mid-stage trials -CYTH
** Up to last close, stock up ~12.7% YTD
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug